Surgical Retractors Market: What’s Driving Growth in the Industry?

The global surgical retractors market size was estimated at USD 2.2 billion in 2024 and is projected to reach USD 3.3 billion by 2030, expanding at a CAGR of 6.8% from 2025 to 2030. Market growth is driven by a significant rise in surgical procedure volume due to the increasing prevalence of chronic diseases, advancements in surgical technologies, growing adoption of minimally invasive surgeries, an expanding geriatric population, and strong R&D efforts by leading market participants.

According to the WHO, 17.9 million people die each year from cardiovascular diseases, and coronary artery bypass grafting remains a standard treatment for blocked arteries. Companies such as B. Braun and Medtronic plc provide a wide portfolio of surgical tools used in cardiovascular procedures. Data from the World Federation of Neurology indicates that 12.0% of neurological patients die from these conditions annually, and Medico Experts reports that 22.6 million people suffer neurological injuries, of which 13.8 million require surgery. Furthermore, WHO estimates that Disability-Adjusted Life Years (DALYs) lost due to neurological conditions will increase from 95 million in 2015 to 103 million in 2030. With surgery being a key treatment option for neurological disorders, the rising number of neurosurgeries and demand for specialized retractors is expected to support market growth.

Awareness of women’s health is also increasing surgical volumes. A WHO article published in June 2023 states that polycystic ovary syndrome (PCOS) affects 8–13% of women of reproductive age, while 70% remain undiagnosed, contributing to more diagnostic and surgical interventions and boosting demand for surgical retractors.

Manufacturers are increasingly focusing on advanced, innovative retractor designs to strengthen their market position. For example, in 2019, Thompson Surgical introduced a table-mounted hip retraction system that uses flexible tethers to stabilize retractor blades while reducing staffing needs. In October 2020, June Medical launched a Galaxy II retractor specifically designed for male anatomy, featuring a penile hammock to lower the risk of sharp hook penetration and reduce infection. In April 2022, Cureus developed a cost-effective 3D-printed retractor aimed at improving surgeon comfort during pedicle screw insertion in transforaminal lumbar interbody fusion surgeries.

Order a free sample PDF of the Surgical Retractors Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

• North America held a dominant market share of 30.3% in 2024. According to the American Hospital Association’s 2024 statistics, the U.S. has around 6,120 operational hospitals, performing 40–50 million surgeries annually for conditions like cancer, trauma, and cardiovascular diseases. Additionally, 702,880 heart disease deaths in 2022 underscore the growing demand for minimally invasive techniques and associated surgical instruments, including retractors.
• By type, the handheld retractors segment accounted for 53.2% of the market in 2024. These retractors help maintain tissue positioning but require a surgeon or medical assistant to hold them, limiting hand availability. A wide variety exists, including rectal, nerve, abdominal, orthopedic, thoracic, and ribbon retractors. In June 2021, Ethicon launched the ENSEAL X1 Curved Jaw Tissue Sealer, designed to offer improved sealing performance in bariatric, gynecological, colorectal, and thoracic surgeries.
• By product, orthopedic retractors held 18.4% of the revenue share in 2024 and are expected to grow at the fastest CAGR. These devices protect incisions and provide access to surgical sites, handling tissues such as arteries, veins, tendons, and muscles. Examples include Applied Medical Resources’ Alexis orthopedic protector/retractor and Thompson Surgical’s hip tether system. In June 2023, Thompson Retractor introduced the Pectus Assist System, a dual-purpose device supporting procedures for both Pectus Excavatum and Pectus Carinatum.
• By application, the neurosurgery segment is projected to grow at a CAGR of 7.8%. Increasing numbers of orthopedic patients also contribute to the demand for retractors. For example, Gelenk Klinik orthopedic hospital treats more than 24,000 patients annually, performing 2,400 surgeries each year, supporting the need for orthopedic and neurosurgical retractors.
• By end use, the hospital segment dominated with 49.3% of the revenue share in 2024. Hospitals perform the majority of preventive and complex surgeries. According to the CDC, 125.7 million outpatient visits were recorded in the U.S., highlighting the growing need for surgical equipment. Rising trauma cases and high volumes of procedures such as angioplasty and organ transplants drive demand for retractors in hospital settings.

Market Size & Forecast

• 2024 Market Size: USD 2.2 Billion
• 2030 Projected Market Size: USD 3.3 Billion
• CAGR (2025-2030): 6.8%
• North America: Largest market in 2024

Key Companies & Market Share Insights

The market features several established manufacturers of surgical retractors. Access to raw materials and advanced manufacturing capabilities significantly affects final product pricing. In developing countries, product differentiation and cost remain major factors influencing purchasing decisions, especially where reimbursements are mostly provided by private insurers. Companies also focus on strategic collaborations, partnerships with local distributors, and regional product variations to strengthen their global presence.

For instance, in March 2021, Ascension—one of the largest non-profit health systems in the U.S.—partnered with Regent Surgical Health to enhance access to high-quality outpatient surgical services. The competitive landscape remains intense, with key players such as MC10, Xenoma, and VivaLNK adopting strategies including product launches, acquisitions, collaborations, and geographic expansion.

Key Players

• Medtronic
• BD
• Medical Devices Business Services, Inc.
• Teleflex Incorporated
• Medline Industries, Inc.
• B. Braun Melsungen AG
• Applied Medical Resources Corporation
• Thompson Surgical
• Innomed, Inc.
• LiNA Medical ApS
• Vivo Surgical Private Limited
• BVI
• CooperSurgical Inc.
• Stryker
• Terumo Corporation
• June Medical Group
• Mediflex Surgical Products
• Chamfond Biotech Co., Ltd
• Applied Medical Technology, Inc. (AMT)
• Microcure (Suzhou) Medical Technology Co., Ltd.
• Boston Scientific Corporation
• Coloplast

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global surgical retractors market is set for steady expansion, supported by rising surgical volumes, increasing incidences of chronic and neurological diseases, and growing adoption of minimally invasive procedures. Innovations in retractor design and ongoing R&D investments further strengthen market growth prospects. North America maintains its leading position due to high surgical activity, while global initiatives for women’s health and the aging population continue to fuel demand. With the market expected to reach USD 3.3 billion by 2030 at a CAGR of 6.8%, surgical retractors will remain essential tools in delivering safe, efficient, and advanced surgical care worldwide.